Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP453534.RAyeHqJIfR4_UinE6tMYbzsz0AHMmWOjz9ZA2hy5od7PM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP453534.RAyeHqJIfR4_UinE6tMYbzsz0AHMmWOjz9ZA2hy5od7PM130_assertion type Assertion NP453534.RAyeHqJIfR4_UinE6tMYbzsz0AHMmWOjz9ZA2hy5od7PM130_head.
- NP453534.RAyeHqJIfR4_UinE6tMYbzsz0AHMmWOjz9ZA2hy5od7PM130_assertion description "[Therapeutic measures include interferon-alpha for CDA I, splenectomy for CDA II, and iron depletion for all individuals at risk for secondary hemochromatosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP453534.RAyeHqJIfR4_UinE6tMYbzsz0AHMmWOjz9ZA2hy5od7PM130_provenance.
- NP453534.RAyeHqJIfR4_UinE6tMYbzsz0AHMmWOjz9ZA2hy5od7PM130_assertion evidence source_evidence_literature NP453534.RAyeHqJIfR4_UinE6tMYbzsz0AHMmWOjz9ZA2hy5od7PM130_provenance.
- NP453534.RAyeHqJIfR4_UinE6tMYbzsz0AHMmWOjz9ZA2hy5od7PM130_assertion SIO_000772 15278299 NP453534.RAyeHqJIfR4_UinE6tMYbzsz0AHMmWOjz9ZA2hy5od7PM130_provenance.
- NP453534.RAyeHqJIfR4_UinE6tMYbzsz0AHMmWOjz9ZA2hy5od7PM130_assertion wasDerivedFrom befree-2016 NP453534.RAyeHqJIfR4_UinE6tMYbzsz0AHMmWOjz9ZA2hy5od7PM130_provenance.
- NP453534.RAyeHqJIfR4_UinE6tMYbzsz0AHMmWOjz9ZA2hy5od7PM130_assertion wasGeneratedBy ECO_0000203 NP453534.RAyeHqJIfR4_UinE6tMYbzsz0AHMmWOjz9ZA2hy5od7PM130_provenance.